Vertical: CNMBase Year: 2025
Market Size (2025)
$1.35B
Projected (2032)
$1.72B
CAGR (2022–2032)
4.2%
Key Players
10+
Market Overview
The global microemulsion market was valued at USD 1,350.2 million in 2025 and is projected to reach USD 1,722.5 million by 2032, registering a CAGR of 3.43% over the 2026–2032 forecast period. The market expanded from USD 1,143.1 million in 2022 to USD 1,285.4 million in 2024, and is expected to add USD 372.4 million in absolute value between 2025 and 2032. Microemulsions — thermodynamically stable, optically transparent dispersions of oil and water stabilised by surfactant and co-surfactant films — are used wherever a lipophilic active ingredient must be delivered in a stable, finely dispersed and readily dilutable form. Their commercial relevance is concentrated in oral and topical drug delivery, crop protection formulations, oilfield stimulation and recovery fluids, and a broad group of personal care, food and industrial uses.
Growth over the forecast period is underpinned by the rising proportion of poorly water-soluble molecules in pharmaceutical pipelines, the regulatory and commercial shift away from solvent-heavy emulsifiable concentrates in crop protection, and the sustained use of microemulsion surfactant systems in well completions and enhanced oil recovery. Moderating these drivers are the high surfactant loadings that microemulsions require, the sensitivity of oilfield chemical demand to upstream spending cycles, and competition from alternative delivery technologies such as amorphous solid dispersions, nanoemulsions and suspension-based formulations.
Key Findings
By application: Pharmaceuticals is the largest segment, accounting for 30.0% of the market in 2025 (USD 405.0 million), and is also the fastest-growing segment with a CAGR of 4.09%. Agrochemicals and Oilfield each account for 25.0% of 2025 value.
By emulsion type: Oil-in-Water is both the largest and the fastest-growing type, with a 65.0% share in 2025 (USD 877.6 million) and a CAGR of 3.66%.
By region: Asia Pacific is the leading region with 45.0% of global value in 2025 (USD 607.6 million), while Middle East & Africa is the fastest-growing region at a CAGR of 3.91%.
By country: China is the leading country market, valued at USD 243.0 million in 2025 (18.0% of the global market), while India is the fastest-growing country with a CAGR of 4.63% over 2026–2032.
Segmentation Summary
The market is analysed by application (Pharmaceuticals, Agrochemicals, Oilfield and Others), by emulsion type (Oil-in-Water and Water-in-Oil) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level detail for 20 country and sub-regional markets. Table 1.1 summarises the largest and fastest-growing segment in each segmentation.
Competitive Landscape Summary
The competitive landscape is moderately fragmented. Large diversified specialty chemical producers — including BASF, Croda International, Evonik Industries, Dow, Clariant, Syensqo, Nouryon and Stepan Company — supply the surfactants, co-surfactants, oils and solubilisers from which microemulsions are built, and increasingly offer ready-to-use concentrates and formulation support. They compete alongside specialist players such as Gattefossé in lipid-based pharmaceutical excipients and Flotek Industries in oilfield microemulsion chemistry. Competition centres on formulation know-how, regulatory documentation (pharmacopoeial compliance, inert-ingredient clearances and offshore chemical notifications), bio-based and low-toxicity portfolios, and technical service close to formulators. Portfolio reshaping through divestments, spin-offs and capacity investments in bio-based surfactants has been the dominant strategic theme since 2022.
Challenges and Opportunities
The principal challenges are the high surfactant and co-surfactant concentrations needed to form stable microemulsions, which raise cost and can raise irritation or toxicity concerns in pharmaceutical and agricultural uses; the narrow phase-behaviour windows that make formulations sensitive to temperature, salinity and dilution; and the volatility of ethylene-oxide and oleochemical feedstock prices. Opportunities lie in self-microemulsifying drug delivery systems for lipophilic and difficult-to-formulate molecules, solvent-reduced and bio-based crop protection formulations that meet tightening co-formulant rules, chemical enhanced oil recovery programmes in mature fields, and fast-growing demand in India, Latin America and the Middle East.
Future Outlook
The market is expected to grow steadily rather than rapidly, rising from USD 1,407.2 million in 2026 to USD 1,722.5 million in 2032. Pharmaceuticals is projected to strengthen its lead, reaching USD 541.6 million by 2032, and Oil-in-Water systems will remain the dominant type. Asia Pacific will continue to account for the largest share of incremental value, reaching USD 785.6 million by 2032, while Middle East & Africa and Latin America are expected to post the highest regional growth rates. Suppliers that combine bio-based raw materials, regulatory dossiers and application laboratories close to formulators are best positioned to capture this growth.
The Microemulsion Market market is projected to grow at a CAGR of 4.2% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
A microemulsion is a thermodynamically stable, isotropic and optically transparent or translucent dispersion of two immiscible liquids — typically an oil phase and an aqueous phase — stabilised by an interfacial film of surfactant, frequently in combination with a co-surfactant such as a short- or medium-chain alcohol or glycol ether. Unlike conventional emulsions, microemulsions form spontaneously or with minimal energy input, exhibit dispersed-phase domains generally in the range of about 10 to 100 nanometres, and do not separate over time under stable conditions of composition and temperature. Depending on the relative proportions of oil, water and surfactant, microemulsions occur as oil-in-water (O/W), water-in-oil (W/O) or bicontinuous structures, conventionally described by the Winsor I–IV classification of phase behaviour.
For the purpose of this study, the microemulsion market comprises the value of microemulsion formulations and microemulsion-forming concentrates supplied for the following uses:
Included: pharmaceutical microemulsions and self-microemulsifying drug delivery systems (SMEDDS) for oral, topical, transdermal, ophthalmic and parenteral administration; agrochemical microemulsion (ME) formulations and microemulsion-based adjuvant systems; oilfield microemulsion surfactant systems used in well stimulation, fracturing, well cleaning and chemical enhanced oil recovery; and microemulsions used in personal care, food and beverage, metalworking fluids, cleaning and other industrial applications (grouped as Others).
Excluded: conventional (kinetically stabilised) macroemulsions such as emulsions in water (EW) and creams; nanoemulsions produced by high-energy processes that are not thermodynamically stable; emulsifiable concentrates (EC) and suspension concentrates (SC); and bulk surfactants, oils and solvents sold for uses unrelated to microemulsion systems.
Scope of the Study
The study covers the global microemulsion market across the following segmentations, reproduced exactly from the underlying market model:
By Application: Pharmaceuticals, Agrochemicals, Oilfield and Others.
By Emulsion Type: Oil-in-Water and Water-in-Oil.
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); and Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
The study timeline comprises historic years 2022, 2023 and 2024, base year 2025 and a forecast period of 2026 to 2032. Compound annual growth rates refer to the 2026–2032 period. All market values are presented in USD Million.
Research Objectives
To define and measure the size of the global microemulsion market for the historic years 2022–2024 and the base year 2025, and to forecast it for 2026–2032 in USD Million.
To analyse the market by application (Pharmaceuticals, Agrochemicals, Oilfield and Others) and by emulsion type (Oil-in-Water and Water-in-Oil), identifying the largest and fastest-growing segments.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa, including segment splits within each country market.
To identify the drivers, restraints, opportunities, trends and challenges shaping microemulsion demand, with particular attention to drug solubility challenges, crop protection formulation regulation and upstream oil and gas activity.
To examine the value chain from surfactant, co-surfactant and oil-phase raw materials through formulation and distribution to end users.
To evaluate competitive intensity using Porter's Five Forces and to map the macro-environment through PESTEL analysis.
To review the regulatory frameworks governing excipients, pesticide co-formulants, chemical registration and offshore chemical use in the major regions.
To profile the competitive positioning of leading suppliers and track product launches, acquisitions, partnerships and capacity expansions since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process. It began with a definition of the market boundary and segmentation, followed by extensive secondary research to build a fact base on microemulsion technologies, end-use industries, raw material supply and regulation. Primary research with participants across the supply and demand sides was then used to validate assumptions, refine segment splits and test forecast drivers. Market size was estimated using both top-down and bottom-up approaches, triangulated to arrive at the final numbers, and forecasts were developed by linking segment demand to quantified macroeconomic and industry indicators. All outputs were subjected to internal consistency checks before finalisation.
Secondary Research
Secondary research drew on sources specific to the surfactant, pharmaceutical excipient, crop protection and oilfield chemical industries, including:
Industry associations: surfactant and detergent industry bodies (such as CESIO in Europe), crop protection associations (such as CropLife International and its regional members), pharmaceutical excipient bodies (such as IPEC), and petroleum industry organisations (such as the American Petroleum Institute and the Society of Petroleum Engineers technical literature).
Government and regulatory bodies: the U.S. FDA (including the Inactive Ingredient Database), the U.S. EPA (pesticide inert ingredient lists and TSCA), the European Chemicals Agency (REACH registration dossiers), the European Medicines Agency, the European Food Safety Authority, national pesticide registration authorities, and energy statistics agencies such as the U.S. Energy Information Administration and the International Energy Agency.
Company filings: annual reports, investor presentations, sustainability reports and press releases of surfactant, excipient and oilfield chemical suppliers.
Trade and scientific journals: pharmaceutical technology, colloid and interface science, pesticide formulation and petroleum engineering journals, as well as patent databases covering microemulsion compositions.
Paid databases: trade statistics, company financial databases and chemical price-reporting services used to benchmark volumes, prices and supplier revenues.
Primary Research
Primary research was conducted through in-depth interviews and structured questionnaires with participants on both sides of the market. On the supply side, respondents included product managers, R&D and application specialists, and business development executives at surfactant, excipient and specialty chemical manufacturers, oilfield chemical suppliers and distributors. On the demand side, respondents included pharmaceutical formulation scientists and contract development and manufacturing organisations, agrochemical formulators and registration specialists, completion and production chemists at oilfield service companies and operators, and procurement managers in personal care and industrial fluid companies. The objectives of primary research were to validate the market definition, confirm segment and regional splits, gather pricing and volume insights, understand adoption barriers and switching behaviour, and test the direction and magnitude of key growth drivers.
Market Size Estimation
Top-down approach: the overall market for surfactants, solubilisers and formulation systems in each end-use industry was established from industry and company data, and the share attributable to microemulsion systems was derived using penetration ratios validated through primary research. These totals were then allocated to regions and countries using industry activity indicators such as pharmaceutical production, crop protection consumption and drilling and completion activity.
Bottom-up approach: demand was built up at country level by estimating the volume of microemulsion formulations consumed in each application — for example, the number of registered microemulsion crop protection products and their use rates, the volume of microemulsion surfactant used per well completion, and the output of microemulsion-based pharmaceutical products — and multiplying by average selling prices. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of the two approaches were compared at segment, regional and global level. Differences were reconciled by revisiting assumptions with primary respondents, and the final estimates were set where the approaches converged within an acceptable tolerance.
Forecasting Methodology
Forecasts for 2026–2032 were developed for each segment and country using a driver-based model. Factors considered included GDP growth and industrial production, pharmaceutical R&D expenditure and the share of poorly soluble molecules in development pipelines, crop protection market growth and the substitution of emulsifiable concentrates, upstream oil and gas capital expenditure and completion activity, raw material and energy price trends, and regulatory changes affecting excipients, co-formulants and chemicals. Historic growth trajectories were used to calibrate the model, and forecasts were reviewed with industry participants to test their plausibility. Scenario analysis was applied to oil price and agricultural commodity price assumptions to assess sensitivity.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032 (CAGR calculated for 2026–2032)
Currency and unit: USD Million, at constant exchange rates
Assumptions and Limitations
Macroeconomic conditions are assumed to remain broadly stable over the forecast period, without a prolonged global recession.
Current regulatory frameworks for excipients, pesticide co-formulants and chemicals are assumed to evolve gradually, without sudden bans on key surfactant classes.
Crude oil prices are assumed to remain within a range that supports continued upstream investment and well completion activity.
Exchange rate fluctuations are not reflected in forecasts; values are expressed at constant currency.
Microemulsion formulations are not separately reported in most public statistics, so segment values rely partly on estimated penetration ratios validated through primary research.
Data for some smaller countries grouped within "Rest of" categories are less granular, and estimates for these markets carry wider uncertainty.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global microemulsion market is moderately fragmented. No single supplier spans all applications with a dominant position; instead, competition is organised around the functional ingredients and formulation expertise required in each end use. Large diversified specialty chemical producers supply surfactants, co-surfactants, solubilisers, oils and adjuvants across pharmaceutical, agrochemical, oilfield and consumer applications, and compete on breadth of portfolio, global manufacturing footprint and application laboratories. Specialist companies hold strong positions in narrower niches — lipid-based pharmaceutical excipients for self-microemulsifying systems, or completion chemistries for unconventional wells — where deep technical know-how and long qualification histories create switching costs.
The nature of competition differs by application. In pharmaceuticals, excipient suppliers compete on regulatory documentation, compendial grades, purity and formulation support, and once an excipient is specified in an approved product it is rarely replaced. In agrochemicals, emulsifier and adjuvant suppliers compete on formulation performance, co-formulant compliance and bio-based credentials, with generic formulators in China, India and Brazil an increasingly important customer base. In oilfield applications, chemistry suppliers compete on technical service and field results, often through long-term supply agreements with pressure-pumping companies. Since 2022, the landscape has been reshaped by portfolio restructuring — demergers, divestments of non-core oilfield and commodity businesses, and bolt-on acquisitions in lipids and specialty surfactants — and by capacity investments in alkoxylation, bio-based surfactants and pharmaceutical lipids.
Key Player Positioning
Market Leaders
Market leaders combine broad surfactant and formulation-additive portfolios with global manufacturing, a presence across several microemulsion applications and strong application support.
BASF SE (Ludwigshafen, Germany) reported revenue of EUR 59,657 million in FY2025. Its Care Chemicals and Pharma Solutions businesses supply Kolliphor solubilisers and Soluplus for poorly soluble drugs, Agnique adjuvants and Sokalan dispersants for crop protection, and alkoxylate and alkyl polyglucoside surfactants. Under its "Winning Ways" strategy, BASF is combining Verbund-integrated alkoxylation with new bio-based and biodegradable capacity.
Croda International plc (Snaith, U.K.) reported revenue of GBP 1,699.4 million in FY2025. Its Life Sciences segment supplies Super Refined polysorbates and poloxamers, Crodasol solubilisers and lipid-based drug delivery systems, while its Crop Protection business — currently its fastest-growing Life Sciences unit — provides agricultural polysorbates, emulsifiers and delivery systems for biopesticides. Its strategy targets organic growth with tighter capital spending.
Evonik Industries AG (Essen, Germany) reported revenue of EUR 14.1 billion in FY2025. It supplies BREAK-THRU crop protection adjuvants and emulsifiers, TEGO and ABIL emulsifiers for personal care, pharmaceutical lipids for drug delivery and rhamnolipid biosurfactants. Its strategy focuses on specialty chemistry, bio-based growth areas and cash discipline.
Dow Inc. (Midland, U.S.) reported net sales of USD 39,968 million in FY2025. Its TERGITOL, TRITON and ECOSURF surfactants, glycol ethers and CARBOWAX SENTRY pharmaceutical-grade polyethylene glycols serve as inert ingredients, co-surfactants and solubilisers. Its "Transform to Outperform" programme simplifies the operating model while retaining downstream specialty surfactant businesses.
Clariant AG (Muttenz, Switzerland) reported revenue of CHF 3,915 million in FY2025. Its Care Chemicals segment includes Crop Solutions, Oil Services, Personal & Home Care and ethylene oxide derivatives, offering emulsifiers such as Sapogenat T, adjuvants such as Synergen Guard 100, and polyethylene glycols. Clariant targets local-currency growth of 4–6% and margin improvement by 2027.
Nouryon (Amsterdam, Netherlands and Radnor, U.S.; privately held) reported revenue of USD 5.13 billion in FY2024, its latest publicly reported full year. It supplies agrochemical emulsifiers and adjuvants including Adsee, Ethylan, Agrilan, Berol and Witconate, along with oilfield chemicals and personal care surfactants, and is investing in regional application centres and biodegradable product launches.
Challengers
Challengers have strong positions in surfactant chemistry and selected applications but a narrower application or geographic scope than the leaders.
Stepan Company (Northbrook, U.S.) reported net sales of USD 2,332.1 million in FY2025, of which Surfactants accounted for USD 1,666.0 million. Its Toximul agricultural emulsifier blends and alkoxylated surfactants serve agrochemical, oilfield, cleaning and personal care formulators. Stepan is prioritising higher-value agricultural and oilfield niches using its new Pasadena, Texas alkoxylation capacity, alongside a cost restructuring programme.
Syensqo SA (Brussels, Belgium) reported revenue of EUR 6,140 million in FY2025. Formed through the demerger of Solvay's specialty businesses in December 2023, it supplies Rhodasurf ethoxylate emulsifiers, Geropon dispersants and other agricultural formulation additives through its Novecare business. Following the sale of its Oil & Gas unit in January 2026, Syensqo is pursuing a pure-play specialty strategy with a focus on conventional and biological crop protection formulation.
Niche Players
Niche players are specialists with deep expertise in one application area of the microemulsion market.
Gattefossé (Saint-Priest, France; family-owned since 1880) is a specialist in lipid-based excipients for pharmaceuticals and personal care and does not publish consolidated group revenue. Its Labrasol, Capryol, Gelucire and Labrafac excipients are widely used in self-microemulsifying drug delivery systems, and the company patented SMEDDS technology in 1995. Its strategy centres on bioavailability enhancement and on building a U.S. manufacturing base in Lufkin, Texas.
Flotek Industries, Inc. (Houston, U.S.) reported revenue of USD 237.3 million in FY2025, of which its Chemistry Technologies segment contributed USD 209.8 million. Flotek is known for its Complex nano-Fluid (CnF) technology, a patented solvent–surfactant system based on citrus-derived d-limonene used in well completions, and today markets completion and production chemistries through its Prescriptive Chemistry Management approach alongside data analytics services. A long-term supply agreement with ProFrac anchors its chemistry volumes.
Threat of New Entrants — Medium
Formulation know-how, application laboratories and long qualification cycles in pharmaceuticals and oilfield chemicals create meaningful entry barriers.
Regulatory dossiers — excipient documentation, pesticide co-formulant clearances and offshore chemical notifications — add cost and time for newcomers.
Barriers are lower in industrial and cleaning applications, where regional formulators can enter with standard surfactant blends.
Bargaining Power of Suppliers — Medium
Key surfactant feedstocks such as ethylene oxide and fatty alcohols are produced by a limited number of large integrated producers.
However, multiple global and regional sources exist for most surfactant classes, limiting the leverage of any single supplier.
Pharmaceutical-grade excipients with established regulatory history carry higher switching costs, increasing supplier leverage in that segment.
Bargaining Power of Buyers — Medium
Large agrochemical companies and oilfield service companies purchase in volume and negotiate actively on price.
Pharmaceutical buyers face high switching costs once an excipient is included in an approved product, reducing their bargaining power.
Buyer power is fragmented in personal care and industrial applications.
Threat of Substitutes — High
Amorphous solid dispersions, nanocrystals and nanoemulsions compete with microemulsions for poorly soluble drugs.
Suspension concentrates, oil dispersions and capsule suspensions compete with ME formulations in crop protection.
Alternative surfactant packages and non-microemulsion additives can substitute in fracturing and well treatment fluids.
Competitive Rivalry — High
Numerous global specialty chemical producers compete with regional surfactant makers and specialist formulators.
Competition is based on technical service, regulatory support, sustainability credentials and price, with frequent product launches.
Portfolio restructuring and consolidation since 2022 have intensified competition for formulation customers.
Threat of New Entrants: Medium; Formulation expertise and regulatory dossiers offset by low barriers in industrial uses.
Bargaining Power of Suppliers: Medium; Concentrated feedstocks but multiple surfactant sources.
Bargaining Power of Buyers: Medium; Strong volume buyers in agro and oilfield; high switching costs in pharma.
Threat of Substitutes: High; Competing delivery and formulation technologies in every application.
Competitive Rivalry: High; Many global and regional suppliers competing on service and sustainability.
Market estimates by geography (2032)
InsightAsia Pacific leads with $785.64M by 2032, while Middle East & Africa is projected to grow fastest at a 4.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $230.90M | $291.34M | $338.82M | 3.9% | 20% |
| Europe | $255.94M | $318.88M | $367.58M | 3.7% | 21% |
| Asia Pacific | $510.28M | $662.22M | $785.64M | 4.4% | 46% |
| Latin America | $78.87M | $103.41M | $123.50M | 4.6% | 7% |
| Middle East & Africa | $67.10M | $88.91M | $106.97M | 4.8% | 6% |
| Total | $1.14B | $1.46B | $1.72B | 4.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.72B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Pharmaceuticals | $541.56M | 5.0% | 31% |
| Agrochemicals | $439.24M | 4.5% | 26% |
| Oilfield | $415.47M | 3.6% | 24% |
| Others | $326.24M | 3.3% | 19% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Microemulsion Market covering market dynamics, competitive landscape, and strategic outlook.
The Microemulsion Market market is projected to reach $1.72B by 2032, growing at 4.2% CAGR. The Pharmaceuticals segment holds the largest share.
The microemulsion market sits at the intersection of three large end-use industries — pharmaceuticals, crop protection and oil and gas — each with its own investment cycle and regulatory environment. Demand is shaped by structural factors such as the physicochemical profile of new drug molecules, the regulation of solvents and co-formulants in pesticide products, and the intensity of well completion and enhanced recovery activity, as well as by cyclical factors such as crude oil and agricultural commodity prices. This chapter assesses these forces. Section 4.2 presents a growth factor analysis in which each macro and micro factor is assigned an impact type and an impact score out of 10 for three forecast sub-periods; the scores are analyst assessments based on secondary research and primary interviews, where higher scores indicate a stronger influence on market growth in the direction indicated.
Growing Share of Poorly Water-Soluble Drug Molecules
Poor aqueous solubility is one of the most persistent obstacles in pharmaceutical development. Pharmaceutical literature commonly reports that around 40% of marketed drugs and a substantially larger share of development candidates fall into Biopharmaceutics Classification System classes II and IV, where low solubility limits oral bioavailability. Microemulsions and self-microemulsifying drug delivery systems (SMEDDS) address this by presenting the drug in a pre-dissolved state that disperses into fine droplets in the gastrointestinal tract, improving absorption and reducing food effects. The approach has an established regulatory track record, beginning with the microemulsion preconcentrate formulation of cyclosporine introduced in the 1990s, and is supported by the availability of compendial lipid excipients, polyoxyl castor oils, polysorbates and glycol ethers whose acceptable levels are documented in the U.S. FDA Inactive Ingredient Database. As pipelines include more lipophilic small molecules, oncology drugs and lipid-soluble vitamins and nutraceuticals, formulators are turning to microemulsion platforms earlier in development. Contract development and manufacturing organisations have expanded their lipid-based formulation and softgel capabilities, making the technology accessible to small and mid-sized drug developers and supporting sustained growth of the pharmaceutical segment.
Shift Toward Safer, Solvent-Reduced Crop Protection Formulations
Crop protection formulators have historically relied on emulsifiable concentrates in which the active ingredient is dissolved in aromatic hydrocarbon or other organic solvents. Regulatory and stewardship pressure has steadily raised the cost of this approach. In the European Union, Commission Regulation (EU) 2021/383 added a list of co-formulants that are not accepted in plant protection products to Annex III of Regulation (EC) No 1107/2009, while solvents such as N-methyl-2-pyrrolidone face restrictions under REACH. Similar scrutiny of inert ingredients applies in the United States under EPA's pesticide inert ingredient programme. Microemulsion (ME) formulations — identified by their own code in the international formulation coding system maintained by CropLife International and used in FAO/WHO pesticide specifications — reduce solvent content, use water as the continuous phase, offer lower flammability and odour, and deliver the active ingredient in a finely dispersed form that can improve leaf coverage and uptake. Growing crop protection demand in Brazil, India, China and Southeast Asia, combined with registrations of new ME products by both multinational and generic agrochemical companies, is expanding the agrochemical segment.
Use of Microemulsion Surfactant Systems in Oilfield Operations
In oil and gas production, microemulsion surfactant systems are used as additives in hydraulic fracturing and acidising fluids to lower interfacial tension and capillary pressure, improving the recovery of injected fluids and the flow of hydrocarbons from tight formations. They are also used in well cleaning, the removal of paraffin and asphaltene deposits, drilling fluid displacement, and chemical enhanced oil recovery, where surfactant formulations are designed to form Winsor type III microemulsions at reservoir salinity to mobilise residual oil. Unconventional development in the United States, Argentina's Vaca Muerta and western Canada, together with chemical EOR programmes at mature fields in China, the Middle East and other producing regions, sustains demand. National oil companies in the Gulf continue to invest in production capacity and recovery-factor improvement, which supports the above-average growth of the Oilfield segment in Middle East & Africa, even as overall global oilfield growth is tempered by operator capital discipline.
Demand for Transparent, Stable Formulations in Consumer and Industrial Products
Outside the three core applications, microemulsions are valued for their clarity, stability and solubilising power. In personal care, they are used in clear serums, cleansing oils, fragrance solubilisation and hair care products; in food and beverages, flavour oil and vitamin microemulsions allow lipophilic ingredients to be incorporated into clear drinks; and in industrial uses, semi-synthetic metalworking fluids, hard-surface cleaners and degreasers rely on microemulsion structures to combine oil-based performance with water dilution. Consumer preference for clean-label and visually appealing products, the growth of premium skin care in Asia, and the shift from neat oils to water-dilutable metalworking fluids in machining operations all support steady demand in the Others segment. Regulatory pressure on volatile organic compound emissions in consumer and industrial products, together with workplace health requirements in machining operations, further favours water-dilutable microemulsion systems over solvent-based or neat-oil alternatives. Suppliers are responding with ready-to-dilute microemulsion concentrates, mild bio-based surfactant packages and solubiliser systems that allow brand owners to reformulate without sacrificing clarity or stability.
Self-Microemulsifying Systems for Complex and Lipophilic Molecules
SMEDDS and related lipid-based formulations filled into soft or hard capsules offer a route to commercialise lipophilic molecules, cannabinoids, fat-soluble vitamins and some peptide and macromolecule candidates for oral delivery. Suppliers that provide pre-qualified excipient combinations, regulatory support files and formulation services can capture value at the early development stage, when excipient selection is locked in for the lifetime of the product.
Bio-Based and Biodegradable Surfactant Systems
Biosurfactants such as rhamnolipids and sophorolipids, sugar-based surfactants such as alkyl polyglucosides, and surfactants made from renewable or bio-attributed feedstocks open opportunities for microemulsions with improved biodegradability and lower aquatic toxicity. These are particularly relevant to crop protection, personal care and offshore oilfield uses, where environmental profiles influence registration and customer choice. Capacity investments by major producers in bio-based surfactants since 2022 indicate that cost gaps with conventional surfactants are narrowing.
Growth in Emerging Agricultural and Pharmaceutical Markets
India, Brazil, Argentina, Mexico and the Gulf states combine expanding agricultural output, growing domestic pharmaceutical manufacturing and, in several cases, significant oil and gas activity. India records the highest country growth rate in this study, and Latin America and Middle East & Africa grow faster than the global average. Local formulation, toll manufacturing partnerships and regional technical centres offer suppliers a means to capture this growth.
High Surfactant Loading, Cost and Tolerability Concerns
Forming a thermodynamically stable microemulsion typically requires substantially higher surfactant and co-surfactant concentrations than a conventional emulsion. This raises raw material cost and, in pharmaceutical products, can cause gastrointestinal irritation or limit the dose that can be administered within accepted excipient levels. In agrochemicals, high surfactant content can increase phytotoxicity risk and complicates eco-toxicological assessments of co-formulants. These constraints limit the use of microemulsions to applications where the performance benefit justifies the higher cost and regulatory burden.
Formulation Complexity and Phase Stability
Microemulsions exist only within defined regions of the phase diagram. Changes in temperature, electrolyte concentration, dilution or the addition of other components can cause phase separation or the formation of liquid crystalline phases. Formulators must therefore invest in extensive phase-behaviour mapping and stability testing, and oilfield systems must be tailored to specific reservoir brines and temperatures. This complexity lengthens development time and favours suppliers with strong application laboratories, raising barriers for smaller formulators.
Exposure to Oil Price and Upstream Spending Cycles
The Oilfield segment is closely tied to drilling and completion activity, which responds to crude oil and natural gas prices. Periods of lower prices or capital discipline among operators reduce chemical consumption and intensify price pressure on suppliers, as reflected in the Oilfield segment's below-average global growth rate over the forecast period.
Challenge: Competition from Alternative Delivery Technologies
In pharmaceuticals, amorphous solid dispersions produced by spray drying or hot-melt extrusion, nanocrystal suspensions and nanoemulsions compete with microemulsions for poorly soluble drugs. In crop protection, suspension concentrates, oil dispersions and capsule suspensions compete with ME formulations. Microemulsion suppliers must demonstrate clear performance or cost advantages to win formulation decisions.
Challenge: Raw Material and Regulatory Cost Pressures
Ethylene oxide derivatives, fatty alcohols and vegetable oils that underpin microemulsion surfactants are exposed to energy, crude oil and palm kernel oil price swings, while compliance with REACH, TSCA and national pesticide and pharmaceutical regulations adds fixed costs. Smaller formulators in particular face margin pressure from these combined cost factors.
Trend: Sustainability-Led Reformulation
Formulators across all applications are reformulating to reduce volatile organic compounds, replace substances of concern and increase renewable carbon content. Microemulsions benefit from this trend where they replace solvent-based systems, but they also face pressure to use biodegradable surfactants and to document environmental fate in more detail.
Trend: Formulation Science Supported by Digital Tools
Suppliers and formulators increasingly use hydrophilic–lipophilic deviation (HLD) models, high-throughput robotic screening and data-driven formulation tools to map phase behaviour and shorten development cycles. These tools reduce the experimental burden that has historically limited microemulsion adoption.
The microemulsion value chain links petrochemical and oleochemical raw material producers with highly specialised formulators and end users. Value addition is concentrated at the surfactant design and formulation stages, where phase-behaviour expertise and regulatory documentation determine performance and market access.
Raw materials and inputs: the oil phase (medium-chain triglycerides, fatty acid esters, vegetable oils, mineral oils, terpenes such as d-limonene, and aromatic or aliphatic solvents), surfactants (non-ionic ethoxylates, polysorbates, sorbitan esters, polyoxyl castor oils, alkyl polyglucosides, lecithins and anionic sulfonates), co-surfactants (short- and medium-chain alcohols, glycols and glycol ethers) and water. These are derived from ethylene, ethylene oxide, propylene oxide, fatty alcohols and plant oils.
Manufacturing and formulation: surfactant and excipient manufacturers produce the functional ingredients and often supply pre-blended microemulsion concentrates. Formulation is carried out by pharmaceutical companies and contract development and manufacturing organisations, agrochemical formulators and toll manufacturers, oilfield chemical suppliers and service companies, and personal care and industrial fluid producers. Phase-behaviour mapping, stability testing and regulatory documentation are critical at this stage.
Distribution and channels: large accounts are served directly by manufacturers, while specialty chemical distributors provide market access, technical service and small-lot supply to mid-sized formulators. Oilfield chemicals are often supplied through service companies as part of completion or production chemical programmes, and crop protection products reach farmers through agricultural retailers and cooperatives.
End users: patients and healthcare providers (through finished pharmaceutical products), farmers and growers, oil and gas operators, and consumers and industrial users of personal care, food, cleaning and metalworking products.
North America
United States: pharmaceutical microemulsions are regulated by the FDA under the Federal Food, Drug, and Cosmetic Act and current Good Manufacturing Practice regulations (21 CFR Parts 210 and 211), with excipient precedence documented in the FDA Inactive Ingredient Database. Pesticide products, including ME formulations, are registered by the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and inert ingredients must be approved, with food-use inerts covered by tolerance exemptions under 40 CFR Part 180. Surfactants and other chemicals are subject to the Toxic Substances Control Act (TSCA), as amended in 2016.
Canada and Mexico: Health Canada regulates drugs and, through its Pest Management Regulatory Agency, pesticides under the Pest Control Products Act, while chemical substances are managed under the Canadian Environmental Protection Act, 1999. In Mexico, COFEPRIS oversees pharmaceutical products and, together with the agriculture and environment authorities, the registration of pesticides.
Europe
Chemicals: Regulation (EC) No 1907/2006 (REACH) governs the registration of surfactants, oils and solvents, and Regulation (EC) No 1272/2008 (CLP) governs classification and labelling. Regulation (EC) No 648/2004 on detergents sets biodegradability requirements for surfactants in detergent products.
Crop protection: Regulation (EC) No 1107/2009 governs plant protection products; Commission Regulation (EU) 2021/383 lists co-formulants not accepted in such products.
Pharmaceuticals and cosmetics: medicinal products are authorised under Directive 2001/83/EC and Regulation (EC) No 726/2004 with excipient quality defined by the European Pharmacopoeia; cosmetic microemulsions fall under Regulation (EC) No 1223/2009. In the United Kingdom, UK REACH and the MHRA apply following the country's exit from the EU.
Offshore oilfield: the OSPAR Harmonised Mandatory Control System governs chemicals used and discharged offshore in the North-East Atlantic, implemented in the U.K. through the Offshore Chemicals Regulations 2002.
Asia Pacific
China: new chemical substances are registered with the Ministry of Ecology and Environment under the Measures for the Environmental Management Registration of New Chemical Substances (MEE Order No. 12); pesticides are registered by the Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA) under the Regulations on Pesticide Administration; and drugs are regulated by the National Medical Products Administration (NMPA).
India: pesticides are registered by the Central Insecticides Board and Registration Committee under the Insecticides Act, 1968, and drugs are regulated by the Central Drugs Standard Control Organisation under the Drugs and Cosmetics Act, 1940.
Japan: industrial chemicals are regulated under the Chemical Substances Control Law, pesticides under the Agricultural Chemicals Regulation Act, and pharmaceuticals under the Pharmaceuticals and Medical Devices Act, with excipient standards set by the Japanese Pharmacopoeia and the Japanese Pharmaceutical Excipients compendium.
Latin America and Middle East & Africa
Brazil: pesticide registration is governed by Law No. 14,785 of 2023, with roles for the Ministry of Agriculture and Livestock (MAPA), ANVISA and IBAMA; ANVISA also regulates medicines and cosmetics.
Gulf states and South Africa: the Saudi Food and Drug Authority and the UAE Ministry of Health and Prevention regulate pharmaceutical products, while South Africa's SAHPRA regulates medicines and the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 governs agricultural remedies.
International Standards
ICH guidelines, including Q8(R2) on pharmaceutical development and Q3C on residual solvents, guide the development of pharmaceutical microemulsions, while the FAO/WHO Manual on the Development and Use of Pesticide Specifications sets specification requirements for ME formulations. The Globally Harmonized System of Classification and Labelling of Chemicals (GHS) underpins hazard communication across regions.
May 2022: Evonik Industries AG; Expansion; Opened its first Applied Technology Center for agricultural markets in Central and South America ("Agro Hub") in Americana, Brazil, supporting BREAK-THRU adjuvants and emulsifiers.
May 2022: Flotek Industries, Inc.; Agreement; Amended its chemical supply agreement with ProFrac to a 10-year term with a minimum purchase obligation, securing long-term demand for its completion chemistries.
Jun 2022: Gattefossé; Expansion; Broke ground on its first North American production site in Lufkin, Texas, for lipid-based excipients.
Aug 2022: BASF SE; Product Launch; Launched the tank-mix adjuvants Agnique Next (plant-based non-ionic surfactant) and Agnique BL 4000c in Brazil.
Sep 2022: Stepan Company; Acquisition; Agreed to acquire the surfactant business and assets of PerformanX Specialty Chemicals to strengthen its alkoxylation capabilities for agricultural and oilfield markets.
Jan 2023: Nouryon; Acquisition; Completed the acquisition of ADOB, a Polish producer of chelated micronutrients and specialty agricultural products.
Feb 2023: Croda International plc; Acquisition; Agreed to acquire Solus Biotech (South Korea), a producer of GMP phospholipids used in drug delivery systems, for about KRW 350 billion.
Mar 2023: Evonik Industries AG; Expansion; Broke ground on a USD 220 million pharmaceutical lipids facility in Lafayette, Indiana, with cost-sharing support from BARDA.
May 2023: Dow Inc.; Product Launch; Launched DOW Crop Solver, an online tool to help agrochemical formulators select inert ingredients, starting in North America.
Jun 2023: BASF SE; Expansion; Announced alkoxylation capacity increases well in excess of 150,000 metric tons per year at Antwerp and Ludwigshafen, serving uses including crop protection additives.
Oct 2023: Dow Inc.; Product Launch / Partnership; Launched EcoSense 2470, a biodegradable surfactant made with LanzaTech using ethylene oxide derived from captured-carbon ethanol.
Oct 2023: Croda International plc; Product Launch; Launched Atlox BS-50, its first product designed specifically for the biopesticide market.
Dec 2023: Syensqo SA; Corporate Restructuring; Completed its partial demerger from Solvay and listed on Euronext Brussels and Paris as an independent specialty chemicals company.
Apr 2024: Clariant AG; Acquisition; Completed the acquisition of Lucas Meyer Cosmetics from IFF for an enterprise value of USD 810 million, strengthening Care Chemicals.
May 2024: Evonik Industries AG; Expansion; Inaugurated the world's first industrial-scale rhamnolipid biosurfactant plant at Slovenská Ľupča, Slovakia.
Jul 2024: Gattefossé; Expansion; Started production of lipid excipients at its Lufkin, Texas plant.
Mar 2025: Clariant AG; Product Launch; Launched Synergen Soil, Synergen Guard 100 (a nano-emulsion adjuvant for biologicals), Dispersogen TP 100 T and Sapogenat T emulsifiers at CAC 2025 in Shanghai.
Mar 2025: Croda International plc; Expansion; Opened an advanced lipids manufacturing facility in Lamar, Pennsylvania.
Apr 2025: BASF SE; Product Launch; Launched Sokalan CP 301, its first readily biodegradable dispersant for agrochemical formulations.
Apr 2025: Stepan Company; Expansion; Started up its alkoxylation plant in Pasadena, Texas, with 75,000 tons per year of capacity serving agricultural, oilfield and other markets.
Apr 2025: Nouryon; Product Launch; Launched Adsee Flex 960, a patented, microplastic-free tank-mix adjuvant, at ISAA 2025 in Brazil.
Jun 2025: Nouryon; Expansion; Opened an innovation centre for oilfield solutions in Houston, Texas, covering drilling, completion, production and stimulation chemistries.
Jun 2025: BASF SE; Expansion; Opened a GMP Solution Center in Wyandotte, Michigan, for pharmaceutical excipients and bioprocessing.
Sep 2025: Croda International plc; Expansion / Product Launch; Expanded its Super Refined excipients facility in Leek, U.K., and launched Super Refined Poloxamer 188.
Sep 2025: Clariant AG; Partnership; Clariant Oil Services and Swire Energy Services opened a bulk oilfield chemical storage and supply base in Stavanger, Norway.
Sep 2025: Gattefossé; Expansion; Formally inaugurated its Lufkin, Texas manufacturing facility, the largest investment in the group's history.
Oct 2025: Syensqo SA; Divestment; Agreed to sell its Oil & Gas business unit, including oilfield stimulation chemicals, to SNF Group for an enterprise value of EUR 135 million.
Nov 2025: BASF SE; Expansion; Inaugurated expanded alkyl polyglucoside surfactant capacity in Bangpakong, Thailand, serving markets including agricultural formulations.
Nov 2025: Clariant AG; Expansion; Completed a CHF 80 million Care Chemicals expansion at Daya Bay, China, adding ethylene oxide derivative capacity for markets including crop protection and pharmaceutical excipients.
Jan 2026: Syensqo SA; Divestment; Completed the divestment of its Oil & Gas business unit to SNF Group.
Mar 2026: Syensqo SA; Product Launch; Launched Geropon D2566, a next-generation dispersant for complex suspension concentrate formulations.
Political
Trade measures and tariffs affecting chemical intermediates, particularly between the United States and China, influence surfactant sourcing and pricing.
Government programmes promoting domestic pharmaceutical manufacturing, such as India's Production Linked Incentive scheme and Saudi Arabia's localisation goals, encourage regional formulation capacity.
Energy policies in producing countries shape upstream investment and oilfield chemical demand.
Economic
Crude oil prices determine drilling and completion activity and therefore oilfield microemulsion demand.
Agricultural commodity prices and farm incomes drive crop protection spending.
Feedstock costs for ethylene oxide, fatty alcohols and vegetable oils affect surfactant margins.
Social
Ageing populations and the rising burden of chronic disease increase demand for oral medicines, including lipid-based formulations.
Consumer preference for clear, stable and natural-positioned personal care and beverage products supports microemulsion use.
Growing public scrutiny of pesticide residues encourages safer formulation types.
Technological
Advances in SMEDDS, supersaturable formulations and lipid excipient science widen pharmaceutical applications.
HLD-based formulation design and high-throughput screening shorten development cycles.
Biotechnology-derived surfactants such as rhamnolipids broaden the sustainable ingredient toolbox.
Environmental
Restrictions on volatile organic compounds and hazardous solvents favour water-continuous microemulsions.
Biodegradability and aquatic toxicity requirements, particularly for offshore discharges, shape surfactant selection.
Sustainable sourcing of palm and palm kernel oil derivatives is increasingly required by customers.
Legal
Chemical registration regimes such as REACH, TSCA and China's new substance registration impose data requirements on surfactant suppliers.
Pesticide co-formulant rules and excipient documentation requirements govern market access.
Patent protection of formulation compositions influences competitive dynamics, especially in pharmaceuticals.
Profiles of 31 companies operating in the Microemulsion Market market, including revenue, employee count, and market positioning where available.
Showing 31 of 31 companies
Nouryon is a carve-out specialty chemicals platform built from the former specialty chemicals arm of AkzoNobel and owned since 2018 by Carlyle and GIC. It manufactures performance ingredients and process chemicals — surfactants, chelates, cellulose ethers, organic peroxides, metal alkyls, colloidal silica, expandable microspheres, chromatography media and pulp-bleaching chemicals — that customers use to make consumer and industrial products. Revenue is roughly $5.1bn, generated through roughly 63 plants and sold in more than 80 countries. Its competitive identity rests on a portfolio of global or regional leadership positions in niche, technically demanding chemistries (Expancel®, Kromasil®, Levasil®, Bermocoll®, Dissolvine®), long-term integrated supply contracts with pulp mills, and a disciplined, Axalta-style private-equity operating model under CEO Charlie Shaver. The investment debate centres on high adjusted EBITDA margins (~22.5%) and solid free cash flow set against heavy leverage (~5.0x), recurring IPO deferrals and cyclic exposure to polymer and pulp markets. --- ### What the company does Nouryon produces specialty and performance chemicals that enter customer formulations or manufacturing processes as functional ingredients, catalysts, initiators or process aids. The company itself characterises its output as "essential solutions" that customers use to manufacture everyday products in attractive end-markets, and it describes the business in its fact sheet as a global specialty chemicals leader operating in more than 80 countries with a portfolio of industry-leading brands (Nouryon company fact sheet). In its 2025 sustainability report the company frames growth as coming from innovating safer, more efficient and more sustainable chemistry for customers (Nouryon 2025 Sustainability Report release, 7 May 2026). ### Company's own description (paraphrased from latest public materials) Nouryon presents itself as a global specialty chemicals leader whose products are used in personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, building products, polymers, pulp and paper, oil and gas, and mining. Since the Q3 2024 reorganisation it organises around three segments — Consumer & Life Sciences, Performance Materials and Resource Solutions — and six business units (FY2024 results release, 7 Mar 2025). ### Independent characterisation Nouryon is best understood as a portfolio of ~30–40 mid-sized niche chemistry franchises sharing a common manufacturing, procurement and commercial backbone. Roughly three economic archetypes coexist: 1. **Formulated consumer ingredients** (surfactants, chelates, cellulose ethers, polymers for home & personal care, agro adjuvants, micronutrients): moderate cyclicality, sticky qualification, pricing tied to raw materials (ethylene oxide, fatty amines, cellulose). 2. **Polymer process chemistry** (organic peroxides, metal alkyls, PVC reactor additives): technically demanding, hazardous-materials handling acts as a barrier to entry; volumes track polyolefin and PVC operating rates, notably in China. 3. **Resource / pulp chemistry** (sodium chlorate, chlorine dioxide, hydrogen peroxide, mining and oilfield chemicals): energy-intensive and contract-based, with 10–15-year integrated "chemical island" supply agreements for pulp mills, especially in South America. ### Business and revenue model | Revenue model element | Estimated share | Comment | |---|---|---| | Product sales (B2B chemicals, spot + contract) | ~95%+ | Core model; priced per tonne, often with raw-material pass-through clauses | | Long-term integrated supply (pulp-mill "Integrated Manufacturing Model") | n/d (embedded in Resource Solutions) | 10–15-year agreements, e.g., Suzano (15-year, 2022), Metsä Fibre (2021), Arauco MAPA (2023), Bracell (2021) | | Technology licensing | Small, n/d | e.g., CiD PVC technology license in China (Jul 2021); SulNOx fuel additive licensing (trade press) | | Services / subscription | Negligible | Digital tools (My Nouryon portal; BeautyCreations™ AI formulation tool) support sales but are not separately monetised (n/d) | ### Value chain position Nouryon sits mid-stream: it buys base chemicals and energy (ethylene, ethylene oxide, fatty raw materials, salt/chlor-alkali derivatives — some from sister company Nobian — cellulose, aluminium, electricity), converts them into functional intermediates, and sells to formulators and manufacturers (consumer goods companies, paint makers, polymer producers, pulp mills, agrochemical formulators, pharma manufacturers). Distribution partners include IMCD and Brenntag Specialties for selected regions and lines. ### Customer types and end-markets | End-market cluster | Representative products | Representative named customers/partners (public) | |---|---|---| | Home & personal care | Surfactants, chelates (Dissolvine®), polymers, CMC, Structure® starches, Armocare® | Henkel Consumer Brands (2025 sustainability award) | | Agriculture & food | Adjuvants (Adsee®), micronutrients (HBED, EDDHA), ADOB fertilizers, food-grade ingredients | n/d | | Pharma & life sciences | Kromasil® chromatography media (peptide/GLP-1 purification) | n/d | | Paints, coatings & inks | Bermocoll® cellulose ethers, Expancel® microspheres, rheology modifiers | n/d | | Polymers | Organic peroxides, metal alkyls (TEAL, MMAO), PVC additives, recycled-PP restoration | Petro Rabigh (2024 supplier award) | | Pulp, paper & packaging | Sodium chlorate, chlorine dioxide plants, hydrogen peroxide, Expancel® for paperboard | Suzano, Arauco, Metsä Fibre, Bracell | | Oil, gas & mining | Demulsifiers, collectors, oilfield surfactants | n/d | | Building & infrastructure | Asphalt additives, cellulose ethers, colloidal silica | Brenntag (US asphalt distribution) | | Electronics, catalysts, batteries | Levasil® colloidal silica, high-purity metalorganics | n/d |
Company Headquarters: Illinois, US Founded: 1932 Workforce: ~2,250 Company Working: Stepan Company (Stepan) is engaged in the manufacturing and sale of specialty and intermediate chemicals. It operates through the segments, namely surfactants, polymers, and specialty products. Surfactants segment offers oilfield biocides along with a wide range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants. The polymers segment produces polyester polyols and phthalic anhydride. The specialty products are chemicals used in food, flavoring, nutritional supplement, and pharmaceutical applications.
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
Clariant is a mid-cap Swiss specialty chemical company that has spent a decade shrinking and upgrading itself. After selling Masterbatches (2020) and Pigments (2022) and exiting bioethanol (2023), it now runs three business units: Care Chemicals (54 % of 2025 sales), Catalysts (21 %) and Adsorbents & Additives (25 %). FY 2025 sales were CHF 3.915 billion with an EBITDA margin before exceptional items of 17.8 %, the third consecutive annual improvement. Its franchise rests on surfactant and ethoxylation chemistry for consumer and industrial formulators, a globally relevant independent process-catalyst business (CATOFIN propane dehydrogenation, syngas, ethylene and specialty catalysts), bentonite-based adsorbents with captive mines, and halogen-free flame retardants and waxes. SABIC holds 31.5 %, which anchors the register and limits free float. The investment debate turns on whether self-help can lift reported margins to the 19–21 % target by 2027 in a flat demand environment, and on a large, unresolved ethylene-cartel damages overhang. Discrepancy note: data aggregators (PitchBook, Morningstar) show 10 449 employees; the company's own year-end 2025 figure is 10 281 FTE. The company figure is used throughout. --- **What the company does.** Clariant develops, manufactures and sells specialty chemicals to formulators, industrial processors and chemical producers. It does not sell to consumers. The Integrated Report 2025 states that the Group mainly addresses consumer, industrial and chemical-process end markets and that, since January 2023, business is conducted through three business units. **Company's own description (paraphrased from 2025–2026 releases).** Clariant presents itself as a focused, sustainability-oriented specialty chemical company guided by the purpose "Greater chemistry – between people and planet", with strategy built on four pillars: customer focus, innovative chemistry, leadership in sustainability and people engagement. **Independent characterisation.** Clariant is a portfolio of three quite different economic models under one balance sheet: 1. Care Chemicals is a formulated-ingredient and surfactant business. A large share of volume is ethylene-oxide-derived chemistry (ethoxylates, polyethylene glycols, glucamides) sold into personal and home care, crop protection formulation, industrial applications, oil services, mining flotation and aircraft de-icing. Part of the industrial book is priced by formula against raw material indices, which stabilises unit margin but passes deflation through to the top line (visible in Q4 2025, when pricing fell 1 % for that reason). 2. Catalysts is a project-and-refill business. Revenue depends on new-build petrochemical plants (first fills) and on replacement cycles at existing customers, which stretch when customer utilisation is low. This produces lumpy quarters and high operating leverage. Catalysts had the highest BU margin in 2025 (20.8 % before exceptional items) on the lowest sales base in five years. 3. Adsorbents & Additives combines a mining-based minerals business (bentonite bleaching earths for edible oil and renewable-fuel purification, foundry additives, desiccants) with polymer additives (phosphorus flame retardants, waxes, stabilisers) exposed to construction, electronics, automotive and coatings. **Revenue model.** Essentially 100 % product sales. Service and licensing income exists but is not reported separately: technical service embedded in catalyst and oil-service contracts, the CLARITY digital catalyst-monitoring platform (over 220 customer plants and over 800 users in 38 countries at end-2025, per the FY 2025 release), and process-technology partnerships. There is no subscription revenue line. Product/service/licensing mix: not publicly disclosed. **Value-chain position.** Midstream. Clariant buys commodity feedstocks (ethylene oxide, fatty alcohols, natural oils, phosphorus derivatives, metals for catalysts, energy) and mines its own bentonite. It sells performance ingredients and catalysts where qualification, application know-how and regulatory approvals matter more than scale. **Customer types.** Consumer goods formulators, agrochemical companies, oil and gas operators, mining companies, airports and airlines, petrochemical and chemical producers, engineering and licensing partners, edible-oil and renewable-fuel refiners, foundries, plastics compounders, and coatings and adhesives producers. **End-market mix.** The Integrated Report 2024 gives chemical-process end markets as 21 % of 2024 sales.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
58 interactive charts drawn from the Microemulsion Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global Microemulsion Market By Region
Global Microemulsion Market By Application
Global Microemulsion Market By Emulsion Type
Global Microemulsion Market — North America by Country
Global Microemulsion Market — North America by Application
Global Microemulsion Market — North America by Emulsion Type
Global Microemulsion Market — Europe by Country
Global Microemulsion Market — Europe by Application
Global Microemulsion Market — Europe by Emulsion Type
Global Microemulsion Market — Asia Pacific by Country
Global Microemulsion Market — Asia Pacific by Application
Global Microemulsion Market — Asia Pacific by Emulsion Type
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
